Nilotinib Ameliorates Folic Acid-Induced Acute Kidney Injury Through Modulation of TWEAK and HSP-70 Pathways.
CONCLUSION: Anti-inflammatory, anti-apoptotic and anti-oxidant potentials are the main mechanisms by which nilotinib can ameliorate folic acid-induced AKI. Modulation of TWEAK and HSP 70 pathways are thought to be the main contributor to the observed ameliorative potential.
PMID: 31593741 [PubMed - as supplied by publisher]
Source: Toxicology - Category: Toxicology Authors: Zaghloul MS, Abdelrahman RS Tags: Toxicology Source Type: research
More News: Antidoxidants | Folic Acid | Nilotinib | Study | Tasigna | Toxicology | Urology & Nephrology | Vitamin B9